Focusing on MM, we found that ST3GAL6-AS1 expression level was independent from the presence of the main genetic aberrations defining MM prognostic groups, apart from chromosome 1q gain, and NRAS or DIS3 gene mutations as shown in the large cohort of MM patients included in the CoMMpass database, (Figure 3a,b). This evidence concerns the gene ST3GAL6 and Miyoshi myopathy.